International Journal of Clinical Oncology

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

International Journal of Clinical Oncology is a journal published by Springer Science+Business Media in Japan. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,390 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1341-9625 · 1437-7772
Country
Japan
Access
Not open access / not declared
Declared publication charge
4,390 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
4,390 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
93 days received→accepted — computed from PubMed (n=93)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

4198

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

93

i10-index

2006

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
98%
ORCID iDs in current deposits
85%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity4
Alternate titles
International journal of clinical oncology (Print
Source type
journal
NLM unique ID (PubMed)
9616295
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Gastric Cancer Management and Outcomes
  • Endometrial and Cervical Cancer Treatments
  • Endometrial and Cervical Cancer Treatments
  • Colorectal Cancer Treatments and Studies
  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Head and Neck Cancer Studies
  • Breast Cancer Treatment Studies
Show all subjects (75)
  • Colorectal Cancer Surgical Treatments
  • Bladder and Urothelial Cancer Treatments
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Gastric Cancer Management and Outcomes
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Cancer Immunotherapy and Biomarkers
  • Bladder and Urothelial Cancer Treatments
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Treatments and Mutations
  • Intraperitoneal and Appendiceal Malignancies
  • Lung Cancer Treatments and Mutations
  • Bladder and Urothelial Cancer Treatments
  • Head and Neck Cancer Studies
  • Renal cell carcinoma treatment
  • Head and Neck Cancer Studies
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Diagnosis and Treatment
  • Colorectal Cancer Surgical Treatments
  • Colorectal Cancer Surgical Treatments
  • Renal cell carcinoma treatment
  • Prostate Cancer Treatment and Research
  • Renal cell carcinoma treatment
  • Prostate Cancer Treatment and Research
  • Esophageal Cancer Research and Treatment
  • Lung Cancer Treatments and Mutations
  • Esophageal Cancer Research and Treatment
  • Sarcoma Diagnosis and Treatment
  • Esophageal Cancer Research and Treatment
  • Prostate Cancer Treatment and Research
  • Inflammatory Biomarkers in Disease Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Inflammatory Biomarkers in Disease Prognosis
  • Cancer Treatment and Pharmacology
  • Cervical Cancer and HPV Research
  • Sarcoma Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Sarcoma Diagnosis and Treatment
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Pancreatic and Hepatic Oncology Research
  • Advanced Radiotherapy Techniques
  • Colorectal and Anal Carcinomas
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Cervical Cancer and HPV Research
  • Cervical Cancer and HPV Research
  • BRCA gene mutations in cancer
  • Colorectal and Anal Carcinomas
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Advanced Radiotherapy Techniques
  • Advanced Radiotherapy Techniques

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: